FOXO TechnologiesFOXOD -65.71%35 9-Day RSI is 31.93 as of Jul. 03, 2026. GuruFocus rates FOXOD with a GF Score™ of 35/100. The stock has 4 warning signs investors should review. Among 700 Healthcare Providers & Services companies, FOXO Technologies ranks better than 89.43% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The industry rank for FOXO Technologies's 9-Day RSI or its related term are showing as below:
FOXOD's 9-Day RSI is ranked better than 89.43% of 700
companies
in the Healthcare Providers & Services industry
Industry Median: 51.335
vs FOXOD: 31.93
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
FOXO Technologies 9-Day RSI Related Terms
FOXOD vs WORX, LGMK, MSPR: 9-Day RSI Comparison
For the Health Information Services subindustry, FOXO Technologies's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
FOXO Technologies 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, FOXO Technologies's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where FOXO Technologies's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FOXO Technologies (FOXOD) has a 9-Day RSI of 31.93 as of Jul. 03, 2026. According to the industry distribution chart, FOXO Technologies ranks #74 out of 700 companies in the Healthcare Providers & Services industry, placing it in the top 10.6%.
Is FOXO Technologies' 9-Day RSI too high?
FOXO Technologies' current 9-Day RSI is 31.93. The Healthcare Providers & Services industry median 9-Day RSI is 51.34. FOXO Technologies' value of 31.93 is 37.8% below this industry median. Based on the distribution chart, FOXO Technologies ranks #74 out of 700 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, FOXO Technologies has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does FOXO Technologies' 9-Day RSI compare to WORX and LGMK?
According to the Healthcare Providers & Services industry distribution chart, FOXO Technologies ranks #74 out of 700 companies for 9-Day RSI. This places FOXO Technologies in the top 11% of its industry — outperforming the majority of peers. The industry median 9-Day RSI is 51.34. FOXO Technologies' value of 31.93 is 37.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 51.34, based on 700 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. FOXO Technologies's current 9-Day RSI of 31.93 is 37.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 51.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. FOXO Technologies's current 9-Day RSI is 31.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FOXO Technologies stock overvalued right now?
FOXO Technologies (FOXOD) has a current 9-Day RSI of 31.93. The current 9-Day RSI is 31.93 and 37.8% below the Healthcare Providers & Services industry median of 51.34. FOXO Technologies' overall GF Score™ is 35/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For FOXO Technologies (FOXOD), the current 9-Day RSI is 31.93 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
FOXO Technologies Inc is a healthcare services and technology company. It currently operates four synergistic divisions: (i) a rural hospital division; (ii) a mental and behavioral health division; (iii) an information, data and biospecimen sourcing division; and (iv) an epigenetics diagnostics and interpretation division. The Company manages and classifies its business into three reportable business segments: (i) Healthcare, (ii) Life Science Services and (iii) Labs. Myrtle, RCHI and SCCH operate under the Healthcare segment and Vector operates under the Life Science Services segment. The company generates majority of its revenue from Healthcare segment. It includes RCHI's hospital, BSF, has 25 inpatient beds, and a 24/7 emergency department and provides ancillary services.
35GF Score
Get the complete analysis for FOXOD
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FOXOD has been successfully added to your 